Novavax Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning. I'm Eric Joseph, senior biotech analyst at JPMorgan. And our next presenting company this morning is Novavax, and it's my pleasure to welcome and introduce Stan Erck and Greg Glenn, CEO -- CEO, Stan Erck and Head of R&D, Greg Glenn, to tell us a little bit about the company.
Just a quick formatting note. There is a Q&A session after the presentation. So to submit a question, just click the blue "Ask a Question" button, and I can submit it or ask it on your behalf, or you can e-mail me at [email protected].
So with that, Stan, let me pass it over to you for the presentation.
Thank you, Eric. And good morning, and thanks for the opportunity to present today. If we can move on to Slide 3, that would be great. And we'll talk about the agenda. So in the next 20 minutes or so, we will discuss where we are today and where we're going this year. I'll take you
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
